Integrated BioPharma (INBP) Stock Overview
Engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
INBP Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Integrated BioPharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.18 |
| 52 Week High | US$0.42 |
| 52 Week Low | US$0.14 |
| Beta | 0.40 |
| 1 Month Change | 1.17% |
| 3 Month Change | 1.17% |
| 1 Year Change | -35.44% |
| 3 Year Change | -32.56% |
| 5 Year Change | -82.66% |
| Change since IPO | -96.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| INBP | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 7.1% | -1.5% | 1.8% |
| 1Y | -35.4% | -3.6% | 13.3% |
Return vs Industry: INBP underperformed the US Personal Products industry which returned -4.7% over the past year.
Return vs Market: INBP underperformed the US Market which returned 11.9% over the past year.
Price Volatility
| INBP volatility | |
|---|---|
| INBP Average Weekly Movement | 11.9% |
| Personal Products Industry Average Movement | 9.1% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: INBP's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: INBP's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 153 | Riva Sheppard | ir.ibiopharma.com |
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
Integrated BioPharma, Inc. Fundamentals Summary
| INBP fundamental statistics | |
|---|---|
| Market cap | US$5.02m |
| Earnings (TTM) | -US$1.65m |
| Revenue (TTM) | US$48.25m |
Is INBP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INBP income statement (TTM) | |
|---|---|
| Revenue | US$48.25m |
| Cost of Revenue | US$46.01m |
| Gross Profit | US$2.24m |
| Other Expenses | US$3.90m |
| Earnings | -US$1.65m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.053 |
| Gross Margin | 4.64% |
| Net Profit Margin | -3.43% |
| Debt/Equity Ratio | 0% |
How did INBP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/21 11:39 |
| End of Day Share Price | 2026/09/21 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Integrated BioPharma, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.